News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jean-Charles Soria: Key insights into the toxicity, efficacy, stability, distribution, and fate of ADCs
Jean-Charles Soria and Raffaele Colombo
Oct 26, 2024, 15:59

Jean-Charles Soria: Key insights into the toxicity, efficacy, stability, distribution, and fate of ADCs

Jean-Charles Soria, Senior Vice President and Oncology Therapeutic Area Head at Amgen, shared a post on LinkedIn:

“ADCs represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs FDA-approved and more than 210 currently being tested in clinical trials.

Spanning over 40 years, ADC clinical development remains challenging as evident from the clinical discontinuation of more than 150 ADCs to date.

This review discussed key insights into the toxicity, efficacy, stability, distribution, and fate of ADCs.”

The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development

Authors: Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, Patricia M. LoRusso, Elisabeth G.E. de Vries.

Jean-Charles Soria

ADCs cancer clinical trials Elisabeth G.E. de Vries FDA Jamie R. Rich Jean-Charles Soria OncoDaily Oncology Paolo Tarantino Patricia M. LoRusso Raffaele Colombo
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues